Phase IIa trial of Locteron in treatment-naive patients with hepatitis C genotype 1 (SELECT-1).

Trial Profile

Phase IIa trial of Locteron in treatment-naive patients with hepatitis C genotype 1 (SELECT-1).

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Apr 2011

At a glance

  • Drugs Interferon alpha-2b; Ribavirin
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SELECT-1
  • Sponsors OctoPlus
  • Most Recent Events

    • 01 Apr 2011 Results published in the Journal of Viral Hepatitis.
    • 02 Nov 2010 Results reported at AASLD, according to a OctoPlus media release.
    • 23 Apr 2008 Updated results presented at EASL 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top